Summary: The Higher Practice Podcast For Optimal Mental Health speaks with MAPS Founder Rick Doblin, Ph.D., about the therapeutic potential for psychedelics to treat mental health conditions. Doblin explains the history of using MDMA in therapy, the progress of MAPS-sponsored clinical trials of MDMA-assisted psychotherapy for the treatment of PTSD, and the inner workings of psychedelic therapy. “What we’re proposing is that the drug is not the treatment. It’s the therapy that’s the treatment that the drug makes more effective,” explains Doblin.
Originally appearing here.
